John Dowling is currently an Associate Principal Scientist at Merck, where they lead therapeutic projects focusing on immunology and molecular biology. With over five years of industry experience, John has successfully driven multiple projects from target identification to candidate selection. Previously, they held roles as Principal Scientist and Senior Research Scientist at Immunome, where they authored IND reports, patents, and publications in prestigious journals. John earned their Ph.D. in Immunology and Microbial Pathogenesis from Thomas Jefferson University, during which they contributed significantly to cancer immunotherapy research and published several first-author papers.
This person is not in the org chart
This person is not in any teams
This person is not in any offices